guest ::
| Home > Publications Database > 9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation. > print |
| Home > Publications Database > 9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation. > print |
| 001 | 136539 | ||
| 005 | 20240321220104.0 | ||
| 024 | 7 | _ | |a 10.1111/j.1471-4159.2012.07713.x |2 doi |
| 024 | 7 | _ | |a pmid:22380576 |2 pmid |
| 024 | 7 | _ | |a 0022-3042 |2 ISSN |
| 024 | 7 | _ | |a 1471-4159 |2 ISSN |
| 024 | 7 | _ | |a altmetric:2841220 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-02861 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Gruss, Michael |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a 9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation. |
| 260 | _ | _ | |a Oxford |c 2012 |b Wiley-Blackwell |
| 264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2012-06-08 |
| 264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2012-06-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1589463366_7797 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a β-Carbolines (BCs) belong to the heterogenous family of carbolines, which have been found exogenously, that is, in various fruits, meats, tobacco smoke, alcohol and coffee, but also endogenously, that is, blood, brain and CSF. These exogenous and endogenous BCs and some of their metabolites can exert neurotoxic effects, however, an unexpected stimulatory effect of 9-methyl-β-carboline (9-me-BC) on dopaminergic neurons in primary mesencephalic cultures was recently discovered. The aim of the present study was to extend our knowledge on the stimulatory effects of 9-me-BC and to test the hypothesis that 9-me-BC may act as a cognitive enhancer. We found that 10 days (but not 5 days) of pharmacological treatment with 9-me-BC (i) improves spatial learning in the radial maze, (ii) elevates dopamine levels in the hippocampal formation, and (iii) results after 10 days of treatment in elongated, more complex dendritic trees and higher spine numbers on granule neurons in the dentate gyrus of 9-me-BC-treated rats. Our results demonstrate that beyond its neuroprotective/neurorestorative and anti-inflammatory effects, 9-me-BC acts as a cognitive enhancer in a hippocampus-dependent task, and that the behavioral effects may be associated with a stimulatory impact on hippocampal dopamine levels and dendritic and synaptic proliferation. |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
| 542 | _ | _ | |i 2015-09-01 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a 9-methyl-beta-carboline |2 NLM Chemicals |
| 650 | _ | 7 | |a Carbolines |2 NLM Chemicals |
| 650 | _ | 7 | |a Central Nervous System Stimulants |2 NLM Chemicals |
| 650 | _ | 7 | |a Dopamine |0 VTD58H1Z2X |2 NLM Chemicals |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Carbolines: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Central Nervous System Stimulants: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Chromatography, High Pressure Liquid |2 MeSH |
| 650 | _ | 2 | |a Cognition: drug effects |2 MeSH |
| 650 | _ | 2 | |a Dendrites: drug effects |2 MeSH |
| 650 | _ | 2 | |a Dopamine: metabolism |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: drug effects |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: metabolism |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: ultrastructure |2 MeSH |
| 650 | _ | 2 | |a Maze Learning: drug effects |2 MeSH |
| 650 | _ | 2 | |a Rats |2 MeSH |
| 650 | _ | 2 | |a Rats, Wistar |2 MeSH |
| 650 | _ | 2 | |a Synapses: drug effects |2 MeSH |
| 700 | 1 | _ | |a Appenroth, Dorothea |b 1 |
| 700 | 1 | _ | |a Flubacher, Armin |0 P:(DE-2719)2809916 |b 2 |u dzne |
| 700 | 1 | _ | |a Enzensperger, Christoph |b 3 |
| 700 | 1 | _ | |a Bock, Jörg |b 4 |
| 700 | 1 | _ | |a Fleck, Christian |b 5 |
| 700 | 1 | _ | |a Gille, Gabriele |b 6 |
| 700 | 1 | _ | |a Braun, Katharina |b 7 |
| 773 | 1 | 8 | |a 10.1111/j.1471-4159.2012.07713.x |b : Wiley, 2012-06-01 |n 6 |p 924-931 |3 journal-article |2 Crossref |t Journal of Neurochemistry |v 121 |y 2012 |x 0022-3042 |
| 773 | _ | _ | |a 10.1111/j.1471-4159.2012.07713.x |g Vol. 121, no. 6, p. 924 - 931 |0 PERI:(DE-600)2020528-4 |n 6 |q 121:6<924 - 931 |p 924-931 |t Journal of neurochemistry |v 121 |y 2012 |x 0022-3042 |
| 909 | C | O | |o oai:pub.dzne.de:136539 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2809916 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |2 G:(DE-HGF)POF3-300 |v Disease Mechanisms and Model Systems |x 0 |
| 914 | 1 | _ | |y 2012 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROCHEM : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-2719)1310005 |k AG Reymann |l Pathophysiology of Dementia |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1310005 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1016/S0928-4257(97)87917-X |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0928-4257(97)87917-X |
| 999 | C | 5 | |y 2010 |2 Crossref |o Appenroth 2010 |
| 999 | C | 5 | |a 10.1073/pnas.96.5.2485 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.96.5.2485 |
| 999 | C | 5 | |y 1996 |2 Crossref |o Collins 1996 |
| 999 | C | 5 | |a 10.1016/j.mcn.2006.05.007 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.mcn.2006.05.007 |
| 999 | C | 5 | |a 10.1016/S0014-2999(99)00573-7 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0014-2999(99)00573-7 |
| 999 | C | 5 | |a 10.1046/j.1460-9568.2003.02624.x |9 -- missing cx lookup -- |2 Crossref |o 10.1046/j.1460-9568.2003.02624.x |
| 999 | C | 5 | |a 10.1016/0306-4522(96)00202-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0306-4522(96)00202-3 |
| 999 | C | 5 | |y 2011 |2 Crossref |o Gille 2011 |
| 999 | C | 5 | |a 10.1111/j.1471-4159.2006.03940.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1471-4159.2006.03940.x |
| 999 | C | 5 | |a 10.1016/j.neuint.2007.08.018 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuint.2007.08.018 |
| 999 | C | 5 | |a 10.1002/jps.2600610602 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/jps.2600610602 |
| 999 | C | 5 | |a 10.1101/lm.459807 |9 -- missing cx lookup -- |2 Crossref |o 10.1101/lm.459807 |
| 999 | C | 5 | |a 10.1016/0166-2236(93)90162-F |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0166-2236(93)90162-F |
| 999 | C | 5 | |a 10.1002/jnr.20092 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/jnr.20092 |
| 999 | C | 5 | |a 10.1073/pnas.0511244103 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.0511244103 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.1454-06.2006 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.1454-06.2006 |
| 999 | C | 5 | |a 10.1016/S0166-2236(96)01028-4 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0166-2236(96)01028-4 |
| 999 | C | 5 | |a 10.1097/00008877-200609000-00012 |9 -- missing cx lookup -- |2 Crossref |o 10.1097/00008877-200609000-00012 |
| 999 | C | 5 | |a 10.1111/j.1471-4159.2008.05703.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1471-4159.2008.05703.x |
| 999 | C | 5 | |a 10.1016/j.nlm.2006.10.001 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.nlm.2006.10.001 |
| 999 | C | 5 | |a 10.1046/j.1471-4159.1998.70020727.x |9 -- missing cx lookup -- |2 Crossref |o 10.1046/j.1471-4159.1998.70020727.x |
| 999 | C | 5 | |a 10.1016/0306-4522(92)90387-H |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0306-4522(92)90387-H |
| 999 | C | 5 | |a 10.1038/nrd3430 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nrd3430 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.15-05-03808.1995 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.15-05-03808.1995 |
| 999 | C | 5 | |a 10.1016/0006-8993(95)00082-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0006-8993(95)00082-2 |
| 999 | C | 5 | |a 10.1038/nm.2165 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nm.2165 |
| 999 | C | 5 | |a 10.1037/0097-7403.2.2.97 |9 -- missing cx lookup -- |2 Crossref |o 10.1037/0097-7403.2.2.97 |
| 999 | C | 5 | |a 10.1016/S0306-4522(00)00182-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0306-4522(00)00182-2 |
| 999 | C | 5 | |a 10.1002/cne.20313 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/cne.20313 |
| 999 | C | 5 | |y 2010 |2 Crossref |o Polanski 2010 |
| 999 | C | 5 | |a 10.1586/ern.11.1 |9 -- missing cx lookup -- |2 Crossref |o 10.1586/ern.11.1 |
| 999 | C | 5 | |a 10.1007/s00415-011-6040-y |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00415-011-6040-y |
| 999 | C | 5 | |y 1953 |2 Crossref |o Sholl 1953 |
| 999 | C | 5 | |a 10.1146/annurev-pathol-011110-130242 |9 -- missing cx lookup -- |2 Crossref |o 10.1146/annurev-pathol-011110-130242 |
| 999 | C | 5 | |a 10.1161/01.STR.29.11.2381 |9 -- missing cx lookup -- |2 Crossref |o 10.1161/01.STR.29.11.2381 |
| 999 | C | 5 | |a 10.1016/S0091-3057(01)00601-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0091-3057(01)00601-3 |
| 999 | C | 5 | |a 10.1016/S1734-1140(10)70241-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1734-1140(10)70241-3 |
| 999 | C | 5 | |a 10.1016/S0306-4522(98)00346-7 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0306-4522(98)00346-7 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.15-07-05169.1995 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.15-07-05169.1995 |
| 999 | C | 5 | |a 10.1038/nrn1406 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nrn1406 |
| 999 | C | 5 | |a 10.1016/j.neuroscience.2010.06.034 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuroscience.2010.06.034 |
| 999 | C | 5 | |a 10.1002/dneu.20543 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/dneu.20543 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|